Mitochondrial therapy of melanoma B16/F10, pathophysiological parameters of tumor regression

Автор: Kit O.I., Frantsiyants E.M., Shikhlyarova A.I., Neskubina I.V., Kaplieva I.V., Trepitaki L.K., Pogorelova Y.A., Cheryarina N.D., Vereskunova A.A., Bandovkina V.A., Surikova E.I., Maksimova N.A., Kotieva I.M., Gusareva M.A., Pozdnyakova V.V.

Журнал: Cardiometry @cardiometry

Рубрика: Original research

Статья в выпуске: 22, 2022 года.

Бесплатный доступ

The aim is to evaluate the pathophysiological parameters of the efficacy of liver mitochondrial transplantation in animals with B16/F10 melanoma. Materials and methods. In our experiment we used female and male mice of BALB/c Nude strain (n=28). Experimental groups were as follows: the reference group (n=14) with B16/ F10 melanoma; the main group (n=14) with B16/F10 melanoma + mitochondrial therapy (MC therapy). Statistical analysis of results was carried out with the Statistica 10.0 software. Results. The subcutaneous tumor in the mice of both sexes became detectable on day 5 from the time of the tumor inoculation, and the regressive effect produced by MC therapy was recorded in the males beginning with day 8 of the tumor growth. At the end of the experiment, on day 22, the difference in the average volumes of the tumor node was reported to be 3.2 times, i.e. a significant inhibition of the tumor growth in the group of the males with MC therapy was revealed. In the females on day 5 of the tumor growth, differences in the volume of the tumor focus between the reference group and the group with MC therapy were not recorded, however, a statistically significant difference was found in the sex-related comparison of the groups of the animals with MC therapy. It was determined that in the females with MC therapy, the area of the tumor spot during that period (5 days) was 1.4 times (p function show_abstract() { $('#abstract1').hide(); $('#abstract2').show(); $('#abstract_expand').hide(); }

Еще

Mitochondrial therapy, mitochondria, b16/f10 melanoma, balb/c nude mice

Короткий адрес: https://sciup.org/148324641

IDR: 148324641   |   DOI: 10.18137/cardiometry.2022.22.5661

Список литературы Mitochondrial therapy of melanoma B16/F10, pathophysiological parameters of tumor regression

  • Jing X, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019; 18:157. doi: 10.1186/s12943-019-1089-9.
  • Dong L, Gopalan V, Holland O, Neuzil J. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy. International journal of molecular sciences. 2020; 21(21): 7941. doi: 10.3390/ijms21217941.
  • Neuzil J, et al. Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion. 2013;13:199208. doi: 10.1016/j.mito.2012.07.112.
  • Mani S, Swargiary G, Singh KK. Natural Agents Targeting Mitochondria in Cancer. Int. J. Mol. Sci. 2020; 21: E6992. doi:10.3390/ijms2119699.
  • Cui Q, Wen S, Huang P. Targeting cancer cell mitochondria as a therapeutic approach: Recent updates. Future Med Chem. 2017; 9:929–949. doi: 10.4155/fmc-2017-0011.
  • Du X, et al. Smart mitochondrial targeted cancer therapy: Subcellular distribution, selective TrxR2 inhibition accompany with declined antioxidant capacity. Int. J. Pharm. 2019; 555: 346–355. doi: 10.1016/j.ijpharm.2018.11.057.
  • Noh I, et al. Enhanced Photodynamic Cancer Treatment by Mitochondria-Targeting and Brominated Near-Infrared Fluorophores. Adv.Sci. 2018; 5: 1700481. doi: 10.1002/advs.20170048.
  • Singh B, Modica-Napolitano JS, Singh KK. Defining the momiome: promiscuous information transfer by mobile mitochondria and the mitochondrial genome. Semin Cancer Biol Semin Cancer Biol. 2017; 47: 1–17. doi:10.1016/j.semcancer.2017.05.004.
  • Roushandeh AM, Kuwahara Y, Roudkenar MH. Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases. Cytotechnology. 2019; 71:647–663. doi: 10.1007/s10616-019-00302-9.
  • Hubbard K, Steinberg ML, Hill H, Orlow I. Mitochondrial DNA deletions in skin from melanoma patients. Ethn Dis. 2008; 18(S2):38-43.
  • Mitra D, et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012; 491:449–453. doi: 10.1038/nature11624.
  • Brown K, et al. WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner. Oncogene. 2017; 36:3119–3136. doi:10.1038/onc.2016.450.
  • Rozenko LY, Sidorenko YS , Frantsiyants EM. Does the volume of the tumor affect the state of the antioxidant defense of the body. Issues of oncology. 1999; 45; 5: 538-41. [in Russian]
  • Frantsiyants ЕМ, et al. The functional state of mitochondria of cardiomyocytes in a malignant process against the background of comorbid pathology in the experiment. South Russian journal of oncology. 2021; 2; 3: 13-22. [in Russian]
  • Kit ОI, et al. The effect of chronic neuropathic pain on the course of the malignant process of B16/ F10 melanoma in male mice. News of higher educational institutions. North Caucasian region. Series: Natural Sciences. 2019; 1 (201):106-111. [in Russian]
  • Frantsiyants ЕМ, et al. Influence of B16/F10 melanoma development variant on cytochrome C content in mitochondria of various organs of female mice. Scientific notes of St. Petersburg State Medical University named after Acad. I.P. Pavlov. 2020; 27; 4:46-52. [in Russian]
  • Kit OI, et al. Influence of standard and stimulated growth of B16/F10 melanoma on aif levels in mitochondria in cells of the heart and other somatic organs in female mice. Cardiometry. 2021; 18: 113-20.
  • Frantsiyants ЕМ, et al. The state of the system of apoptosis factors in the mitochondria of skin and tumor cells during standard and stimulated growth of B16/F10 melanoma in C57BL/6 female mice. Research and practice in medicine. 2021;8; 1:8-19. [in Russian]
  • Kit ОI, et al. The processes of self-organization of mitochondria during the growth of experimental tumors under conditions of chronic neurogenic pain. News of higher educational institutions. North Caucasian region. Series: Natural Sciences. 2019; 2 (202):97-105. [in Russian]
  • Егорова М.В., Афанасьев С.А. Выделение митохондрий из клеток и тканей животных и человека: Современные методические приемы. Сибирский медицинский журнал. 2011;26(1-1):22-28. [in Russian]
  • Ali Pour P, Kenney MC, Kheradvar A. Bioenergetics Consequences of Mitochondrial Transplantation in Cardiomyocytes. J. Am. Heart Assoc. 2020;9:e014501. doi: 10.1161/JAHA.119.014501.
  • Fu A, Shi X, Zhang H, Fu B. Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice. Frontiers in pharmacology. 2017;8:241. doi:10.3389/fphar.2017.00241.
  • Anna Park, et al. Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases. Int J Mol Sci. 2021; 22(9):4793. doi: 10.3390/ijms22094793.
  • Paria Ali Pour, Sina Hosseinian, Arash Kheradvar. Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes. Am J Physiol Cell Physiol. 2021; 321(3):489-503. doi: 10.1152/ajpcell.00152.2021.
  • Chang J-C, et al. Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation. Sci Rep. 2017;7(1):10710. doi: 10.1038/s41598-017-10870-5.
  • Chang J-C, et al. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson’s disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine–induced neurotoxicity. Transl Res. 2016;170:40–56. doi: 10.1016/j.trsl.2015.12.003.
  • Gollihue JL, Patel SP, Rabchevsky AG. Mitochondrial transplantation strategies as potential therapeutics for central nervous system trauma. Neural Regen Res. 2018;13(2):194. 10.4103/1673-5374.226382.
Еще
Статья научная